<DOC>
	<DOCNO>NCT00664534</DOCNO>
	<brief_summary>This study design look best start gradually intensify ( need ) insulin lispro premix regimen type 2 diabetes patient consume light breakfast .</brief_summary>
	<brief_title>Pre-Mix Insulin Lispro Treatment Type 2 Diabetes Patients Who Consume Light Breakfast</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Diabetes Mellitus , Type 2 receive metformin plus least one oral antihyperglycemic medication ( OAM ) ( sulfonylurea Thiazolidinedione [ TZD ] ) without insulin , least 90 day prior Visit 1 glycosylated hemoglobin ( HbA1c ) great equal 7.0 % le 11.0 % regularly consume light breakfast ( le 15 % total daily calorie intake ) capable willing follow protocol give write consent take TZD whose country label allow combination insulin take glucoselowering agent ( specify inclusion criterion ) body mass index great 40 kg/m^2 history severe hypoglycemia past 24 week pregnant may become pregnant woman breastfeed significant cardiac disease significant renal liver disease undergo therapy malignancy contraindication study medication irregular sleep/wake cycle</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>